PROTEINURIC KIDNEY DISEASE
Clinical trials for PROTEINURIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROTEINURIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for PROTEINURIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kidney disease caused by APOL1 gene
Disease control Recruiting nowThis study tests an experimental drug called VX-147 in people with a specific genetic form of kidney disease caused by the APOL1 gene. The goal is to see if the drug can reduce protein in the urine and protect kidney function. About 466 adults and children will take either VX-147…
Matched conditions: PROTEINURIC KIDNEY DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
New hope for kidney disease: targeted drug trial launches
Disease control Recruiting nowThis study tests an experimental drug called MZE829 in 56 adults with chronic kidney disease caused by a specific genetic risk (APOL1). The goal is to see if the drug can safely reduce protein leakage into urine, a key sign of kidney damage. Participants must have the high-risk A…
Matched conditions: PROTEINURIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: Maze Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:06 UTC